(Q37557361)

21 August 2017

1 reference

title

Cardiovascular risk factors in patients with chronic kidney disease (English)

1 reference

21 August 2017

0 references

1 reference

3

1 reference

21 August 2017

Valentín Fuster Carulla

series ordinal

5

1 reference

21 August 2017

Sarina van der Zee

1

1 reference

21 August 2017

Usman Baber

series ordinal

2

1 reference

21 August 2017

Jonathan Winston

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

21 July 2009

1 reference

21 August 2017

number of pages

10

1 reference

Nature Reviews Cardiology

inferred from page(s)

published in

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

580-589

1 reference

Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Card

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Acute myocardial infarction and renal dysfunction: a high-risk combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Cardiovascular disease risk status in elderly persons with renal insufficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Testing for chronic kidney disease: a position statement from the National Kidney Foundation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Predictors of new-onset kidney disease in a community-based population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States, 1991-1999.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Prevalence of chronic kidney disease in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Cardiovascular disease and subsequent kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Advanced atherosclerosis in predialysis patients with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The Framingham predictive instrument in chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Association between serum lipids and survival in hemodialysis patients and impact of race

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Changing relationship of blood pressure with mortality over time among hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Blood pressure and mortality risk on peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Managing dyslipidemia in chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Safety considerations with fibrate therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Peritoneal and hemodialysis: I. Differences in patient characteristics at initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Cardiovascular implications of proteinuria: an indicator of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Mortality risk among hemodialysis patients receiving different vitamin D analogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Meta-analysis: vitamin D compounds in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Correction of anemia with epoetin alfa in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Associations of kidney function with cardiovascular medication use after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.121

Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients

31 March 2020

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study.

1 reference

12 December 2020

Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?

1 reference

12 December 2020

Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study

1 reference

12 December 2020

Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors

1 reference

12 December 2020

K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease

1 reference

12 December 2020

Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.

1 reference

12 December 2020

10.1038/NRCARDIO.2009.121

Identifiers

DOI

1 reference

21 August 2017

1 reference